J&J | JNJ - Capitaux D'Emprunt

Prix De L'Action
243.04
Variation Quotidienne
-1.08 -0.44%
Mensuellement
-1.50%
Annuel
52.07%
Q2 Prévisions
233.24




Capitaux D'Emprunt Changement Date
AbbVie USD 62.97B 12M 2025-09
Abbott USD 9.9B 1.7B 2025-12
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Baxter International USD 9.47B 726M 2025-12
Bayer EUR 31.83B 877M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Biogen USD 6.29B 1.4M 2025-09
Boston Scientific USD 10.99B 12M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
CONMED USD 853.01M 28.1M 2025-09
Cooper Companies USD 1.88B 578.5M 2025-12
Dexcom USD 1.24B 53.6M 2025-12
Edwards Lifesciences USD 598.2M 200K 2025-09
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Globus Medical USD 436K 9K 2025-12
Hologic USD 2.5B 2.1M 2025-12
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 39.44B 30M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merck USD 39.97B 6B 2025-09
Merit Medical Systems USD 734.04M 1.12M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Stryker USD 14.86B 14M 2025-12
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teva Pharmaceutical Industries USD 14.99B 1.78B 2025-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12
Zoetis USD 9.04B 1.97B 2025-12